Cover Image

Potential therapeutic role of budesonide to reduce COVID-19 severity

Saved in:

Bibliographic Details
Main Authors:	Md Mohiuddin (Author), Kazuo Kasahara (Author)
Format:	Book
Published:	Elsevier, 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cancer metastasis may increase COVID-19 mortality: Suitable targets required to impede cancer metastasis
by: Md Mohiuddin, et al.
Published: (2022)

Role of budesonide inhalation in treatment of meconium-aspiration syndrome
by: Zainab S Ahmed, et al.
Published: (2022)

Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice
by: Shiyun Xian, et al.
Published: (2023)

BUDESONIDE TREATMENT IN CHILDREN PRESCHOOL AGE
by: E.A. Vishneva, et al.
Published: (2010)

BUDESONIDE TREATMENT IN CHILDREN PRESCHOOL AGE
by: E.A. Vishneva, et al.
Published: (2010)

Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
by: Xiaoyan Liu, et al.
Published: (2020)

Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
by: Arun Jenish J, et al.
Published: (2012)

A Pharmacokinetic Bridging Study to Compare Systemic Exposure to Budesonide between Budesonide Oral Suspension and ENTOCORT EC in Healthy Individuals
by: Ivy H. Song, et al.
Published: (2020)

The effect of budesonide on orthodontic induced root resorption
by: Hosseinagha Aghili, et al.
Published: (2015)

APPLICATION OF BUDESONIDE IN BREASTFEEDING MOTHERS WITH BRONCHIAL ASTHMA
by: E.A. Vishneva, et al.
Published: (2009)

APPLICATION OF BUDESONIDE IN BREASTFEEDING MOTHERS WITH BRONCHIAL ASTHMA
by: E.A. Vishneva, et al.
Published: (2009)

Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
by: Antonella Casiraghi, et al.
Published: (2020)

New Strategies for Improving Budesonide Skin Retention
by: Cristina Padula, et al.
Published: (2021)

Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS
by: Burak Deliloglu, et al.
Published: (2020)

The therapeutic potential of gelsolin in attenuating cytokine storm, ARDS, and ALI in severe COVID-19
by: Juan Zhi, et al.
Published: (2024)

Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic Esophagitis
by: Antonio Spennacchio, et al.
Published: (2024)

Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients
by: Lin-Yu Kuo, et al.
Published: (2010)

Differentially Expressed Genes Study Shown Potential for BCG Stimulation in Reducing the Severity of COVID-19
by: Irandi Putra Pratomo, et al.
Published: (2022)

Evaluating the effects of processing parameters on budesonide nanocrystals prepared by nanomilling
by: Rebecca Olubi, et al.
Published: (2022)

Effect of Surfactant and Budesonide on the Pulmonary Distribution of Fluorescent Dye in Mice
by: Liang-Ti Huang, et al.
Published: (2015)

Budesonide Attains Its Wide Clinical Profile by Alternative Kinetics
by: Ralph Brattsand, et al.
Published: (2024)

Effect of budesonide on fibroblast-mediated collagen gel contraction and degradation
by: Fang Q, et al.
Published: (2013)

Utility and effectiveness of Symbicort® Turbuhaler® (oral inhalation containing budesonide and formoterol) in a patient with severe asthma after permanent tracheostomy
by: Kohhei Maeda, et al.
Published: (2018)

The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID‐19
by: Cássia L. Braga, et al.
Published: (2020)

Targeted-release budesonide in immunoglobulin A nephropathy; a mini-review
by: Shiva Toumaj, et al.
Published: (2023)

Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
by: Maconi G, et al.
Published: (2021)

The rapid effects of budesonide plus formoterol in patients with obstructive airway diseases
by: Bayiz H, et al.
Published: (2015)

Decreased frequency of adenoidectomy by a 12-week nasal budesonide treatment
by: Hong H, et al.
Published: (2017)

Synthesis of budesonide conjugates and their anti-inflammatory effects: a preliminary study
by: Yan Y, et al.
Published: (2019)

A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: a clinical evaluation
by: N. Ringdal, et al.
Published: (1996)

Ayurvedic formulations: Potential COVID-19 therapeutics?
by: Anees Ahmed Mahaboob Ali, et al.
Published: (2022)

The Potential of Antiviral Peptides as COVID-19 Therapeutics
by: Arun Suria Karnan Mahendran, et al.
Published: (2020)

Therapeutic Potential of Annexins in Sepsis and COVID-19
by: Louise Mui, et al.
Published: (2021)

Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases
by: Atsunori Tsuchiya, et al.
Published: (2020)

The hypoxia index covers roles of all decelerations and will reduce cerebral palsy
by: Kazuo Maeda
Published: (2018)

"Impact of solid state miscibility on quantitive nano-precipitation of budesonide and PVP-VA
by: Hanan Abdalmaula, et al.
Published: (2019)

Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis
by: Zhou H, et al.
Published: (2018)

Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol
by: Peter N Huynh, et al.
Published: (2010)

Saponin Micelles Lead to High Mucosal Permeation and In Vivo Efficacy of Solubilized Budesonide
by: Sabine Nakowitsch, et al.
Published: (2020)

Surfactant-Assisted Distal Pulmonary Distribution of Budesonide Revealed by Mass Spectrometry Imaging
by: Riccardo Zecchi, et al.
Published: (2021)